viernes, 5 de abril de 2019

#FarewellDrG

The Readout
Damian Garde

#FarewellDrG

3c3c03eb-ead2-4257-b1a7-8430ed411081.png
IT'S LIKE "SHANE," BUT WITH TIGHTER PANTS. (@FDA_DRUG_INFO)
Yesterday, we asked readers what would become of Scott Gottlieb after today, his last at the helm of the FDA. Then, about an hour later, the Washington Post published a story in which Gottlieb said he’d take a part-time role at the American Enterprise Institute, a conservative think tank at which he was previously a fellow.

This arguably obviated our survey, but, whatever, here are the results. About 38% predicted Gottlieb would end up back in the world of venture capital, while 28% said he’d become a consultant and 27% figured he’d join some pharma boards. Just 12% said he’d end up at a nonprofit devoted to one of his pet causes.

But you could all still be right. The AEI position will take up just six days a month, Gottlieb told the Post, and his only other plan is taking his family to Disney World, which had better ensure its food preparation is up to code. The point is we still don’t know what Gottlieb’s full-time vocation will be.

In any case, his time at the FDA has come to a close, which the agency celebrated with a Twitter megathread excerpted above. And so farewell, Dr. G. You were tweetastic ’til the end.

No hay comentarios: